{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T14:42:02Z","timestamp":1785595322016,"version":"3.56.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"German Federal Ministry for Education and Research","award":["Grant No. AFG 08\/002"],"award-info":[{"award-number":["Grant No. AFG 08\/002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40249-018-0389-4","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T07:14:22Z","timestamp":1518592462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Health economic evaluation of moist wound care in chronic cutaneous leishmaniasis ulcers in Afghanistan"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6216-8613","authenticated-orcid":false,"given":"Hans-Christian","family":"Stahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faridullah","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami Mohammad","family":"Nahzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng-Jin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt-Wilhelm","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Sauerborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,14]]},"reference":[{"key":"389_CR1","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","volume":"366","author":"HW Murray","year":"2005","unstructured":"Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet. 2005;366:1561\u201377.","journal-title":"Lancet"},{"key":"389_CR2","doi-asserted-by":"crossref","unstructured":"Hepburn NC. Cutaneous leishmaniasis. Clin Exp Dermatol, 2000;25(5):363\u201370.","DOI":"10.1046\/j.1365-2230.2000.00664.x"},{"key":"389_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1186\/s12879-014-0619-8","volume":"14","author":"HC Stahl","year":"2014","unstructured":"Stahl HC, Ahmadi F, Schleicher U, Sauerborn R, Bermejo J, Amirih M, et al. A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan. BMC Infect Dis. 2014;14:619.","journal-title":"BMC Infect Dis"},{"key":"389_CR4","volume-title":"WHO regional publications","author":"Mediterranean WHOROftE","year":"2014","unstructured":"Mediterranean WHOROftE. Manual for case management of cutaneous leishmaniasis in the WHO Eastern Mediterranean Region. In: WHO regional publications; 2014."},{"key":"389_CR5","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7:e35671.","journal-title":"PLoS One"},{"key":"389_CR6","doi-asserted-by":"crossref","unstructured":"Reithinger R. et al. Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan. Emerg Infect Dis,2003. 9(6): p. 727\u20139.","DOI":"10.3201\/eid0906.030026"},{"key":"389_CR7","doi-asserted-by":"crossref","unstructured":"Faulde M. et al. Differences in transmission seasons as an epidemiological tool for characterizationof anthroponotic and zoonotic cutaneous leishmaniasis in northern Afghanistan. Acta Trop, 2008;105(2): p. 131\u20138.","DOI":"10.1016\/j.actatropica.2007.10.011"},{"key":"389_CR8","doi-asserted-by":"crossref","unstructured":"Faulde MK, G Heyl, ML. Amirih. Zoonotic cutaneous leishmaniasis, Afghanistan. Emerg InfectDis, 2006;12(10): p. 1623\u20134.","DOI":"10.3201\/eid1210.060076"},{"key":"389_CR9","unstructured":"Reithinger R. PG Coleman, Treating cutaneous leishmaniasis patients in Kabul, Afghanistan:cost-effectiveness of an operational program in a complex emergency setting. BMC Infect Dis, 2007.7: p. 3."},{"key":"389_CR10","unstructured":"Tan-Torres Edejer TBR, Adam T, Hutubessy R, Acharya A, Evans DB, Murray CJL. WHO guide to cost-effectiveness analysis. Geneva: World Health Organization; 2003;1\u2013329."},{"key":"389_CR11","doi-asserted-by":"crossref","unstructured":"Vega JC. et al. Short communication: The cost-effectiveness of cutaneous leishmaniasis patientmanagement during an epidemic in Chaparral, Colombia in 2004. Trop Med Int Health, 2007.12(12): p. 1540-4.","DOI":"10.1111\/j.1365-3156.2007.01962.x"},{"key":"389_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2174\/1381612023396258","volume":"8","author":"SL Croft","year":"2002","unstructured":"Croft SL, Yardley V. Chemotherapy of leishmaniasis. Curr Pharm Des. 2002;8:319\u201342.","journal-title":"Curr Pharm Des"},{"key":"389_CR13","doi-asserted-by":"crossref","unstructured":"Choudhury K. et al., Identification of a Leishmania infantum gene mediating resistance tomiltefosine and SbIII. Int J Parasitol, 2008. 38(12): p. 1411-23.","DOI":"10.1016\/j.ijpara.2008.03.005"},{"key":"389_CR14","doi-asserted-by":"crossref","unstructured":"Reithinger R, et al. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused byLeishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis, 2005;40(8): p. 1148\u201355.","DOI":"10.1086\/428736"},{"key":"389_CR15","doi-asserted-by":"crossref","unstructured":"Schafer C. et al. Reduced antimony accumulation in ARM58-overexpressing Leishmania infantum.Antimicrob Agents Chemother, 2014. 58(3): p. 1565-74.","DOI":"10.1128\/AAC.01881-13"},{"key":"389_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0738-081X(99)00049-8","volume":"17","author":"PF Moskowitz","year":"1999","unstructured":"Moskowitz PF, Kurban AK. Treatment of cutaneous leishmaniasis: retrospectives and advances for the 21st century. Clin Dermatol. 1999;17:305\u201315.","journal-title":"Clin Dermatol"},{"key":"389_CR17","unstructured":"S3-Leitlinie Lokaltherape chronischer Wunden bei den Risiken CVI, PAVK und Diabetes mellitus. In: AWMF Leitlinien-Register. vol. 091\/001: Deutsche Gesellschaft f\u00fcr Wundheilung und Wundbehandlung e.V."},{"key":"389_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","volume":"7","author":"R Reithinger","year":"2007","unstructured":"Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7:581\u201396.","journal-title":"Lancet Infect Dis"},{"key":"389_CR19","doi-asserted-by":"crossref","unstructured":"Jebran AF. et al., Rapid healing of cutaneous leishmaniasis by high-frequency electrocauterizationand hydrogel wound care with or without DAC N-055: a randomized controlled phase IIa trial in Kabul. PLoS Negl Trop Dis, 2014. 8(2): p. e2694.","DOI":"10.1371\/journal.pntd.0002694"},{"key":"389_CR20","first-page":"CD005067","volume":"4","author":"U Gonzalez","year":"2008","unstructured":"Gonzalez U, Pinart M, Reveiz L, Alvar J. Interventions for old world cutaneous leishmaniasis. Cochrane Database Syst Rev. 2008;4:CD005067.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"389_CR21","first-page":"246ff","volume":"15","author":"O Zeglin","year":"2009","unstructured":"Zeglin O. Infektiologie und Tropendermatologie-Teil 17: Kutane Leishmaniasis - eine Kasuistik mit Nachgegutachtung. Derm. 2009;15(4):246ff.","journal-title":"Derm"},{"key":"389_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","volume":"14","author":"E Handman","year":"2001","unstructured":"Handman E. Leishmaniasis: current status of vaccine development. Clin Microbiol Rev. 2001;14:229\u201343.","journal-title":"Clin Microbiol Rev"},{"key":"389_CR23","doi-asserted-by":"publisher","first-page":"e2130","DOI":"10.1371\/journal.pntd.0002130","volume":"7","author":"P Olliaro","year":"2013","unstructured":"Olliaro P, Vaillant M, Arana B, Grogl M, Modabber F, Magill A, et al. Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis. PLoS Negl Trop Dis. 2013;7:e2130.","journal-title":"PLoS Negl Trop Dis"},{"key":"389_CR24","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3111\/13696998.2013.807268","volume":"16","author":"C Waycaster","year":"2013","unstructured":"Waycaster C, Milne CT. Clinical and economic benefit of enzymatic debridement of pressure ulcers compared to autolytic debridement with a hydrogel dressing. J Med Econ. 2013;16:976\u201386.","journal-title":"J Med Econ"},{"key":"389_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/0272989X9301300409","volume":"13","author":"FA Sonnenberg","year":"1993","unstructured":"Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Mak. 1993;13:322\u201338.","journal-title":"Med Decis Mak"},{"key":"389_CR26","unstructured":"Leporowski A. Health economics of chronic wounds: a systematic literature review. Master thesis. Heidelberg University Hospital; 2015. p. 97."},{"key":"389_CR27","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3201\/eid1104.040945","volume":"11","author":"R Reithinger","year":"2005","unstructured":"Reithinger R, Aadil K, Kolaczinski J, Mohsen M, Hami S. Social impact of leishmaniasis, Afghanistan. Emerg Infect Dis. 2005;11:634\u20136.","journal-title":"Emerg Infect Dis"},{"key":"389_CR28","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision Modelling for health economic evaluation: Oxford university press","author":"KC Andrew Briggs","year":"2006","unstructured":"Andrew Briggs KC, Mark Sculpher. Decision Modelling for health economic evaluation: Oxford university press; 2006."}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-018-0389-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T05:46:09Z","timestamp":1719812769000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-018-0389-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,14]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["389"],"URL":"https:\/\/doi.org\/10.1186\/s40249-018-0389-4","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,14]]},"assertion":[{"value":"1 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical clearance of the health economic evaluation was obtained by the Ethical Committee of the Medical Faculty of the University of Heidelberg, Germany (S-318\/2009, 18th November 2009, Additional\u00a0file\u00a0) and the International Review Board at the Ministry of Public Health in Kabul, Afghanistan (23rd January 2010, Additional\u00a0file\u00a0). The trial was registered online at(ID: NCT00996463, 15th October 2009). Consort statements and flow chart are published in Stahl et al. []. An informed consent was obtained from all participants in the trial and documented digitally.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants gave their informed consent for publications.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}